• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

EmblemHealth Appoints New Chief Medical Officer

By: EmblemHealth via GlobeNewswire
February 11, 2025 at 10:46 AM EST

New York, New York, Feb. 11, 2025 (GLOBE NEWSWIRE) -- EmblemHealth, one of the nation's largest not-for-profit health insurers, today announced the appointment of Dr. Daniel Knecht as its new Chief Medical Officer. As CMO, Dr. Knecht will lead the health plan's clinical strategy which includes innovating care models, improving health outcomes, and enhancing the value of care provided to more than 2 million New Yorkers.

“We are thrilled to welcome Dr. Knecht to EmblemHealth,” said Mike Palmateer, CEO of EmblemHealth. “His deep clinical experience and passion for innovation will be instrumental as we continue to transform care delivery. With Dr. Knecht’s forward-thinking leadership, we are positioned to drive meaningful change, improve health outcomes, and deliver even greater value to the millions of New Yorkers we serve.”

Dr. Knecht brings an extensive wealth of clinical and leadership experience to his new role as CMO. Most recently he served as Chief Clinical Innovation Officer at CVS Caremark where he led the enterprise strategies to enhance patient outcomes, improve healthcare costs, and elevate care delivery. And, previously, as Vice President of Clinical Strategy and Policy at Aetna where he focused on population health, behavioral integration, and addressing social determinants of health. He is a board-certified internist affiliated with Mount Sinai. 

“I am honored to join an organization with such a rich legacy of serving communities and improving lives,” expressed Dr. Knecht. “I look forward to working with the talented team at EmblemHealth to innovate and deliver meaningful health care solutions that put members first. By leveraging our community-based capabilities like AdvantageCare Physicians (ACNPY) and Neighborhood Care locations, we can foster healthier outcomes for New Yorkers.”

Dr. Knecht holds an MD/MBA from Weill Cornell Medical College and a BA in Biochemistry and Molecular Biology from Dartmouth College. A Fullbright Scholar and Modern Healthcare 40 Under 40 honoree, he is an active board member of CUNY School of Public Health Foundation, committed to building a future pipeline of outstanding talent for our health care system.

About EmblemHealth
EmblemHealth is one of the nation’s largest not for profit health insurers, serving members across New York’s diverse communities with a full range of commercial and government-sponsored health plans for employers, individuals, and families. With a commitment to value-based care, EmblemHealth partners with top hospitals and doctors, including its own AdvantageCare Physicians, to deliver quality, affordable, convenient care. At over a dozen EmblemHealth Neighborhood Care locations, members and non-members alike have access to community-based health and wellness guidance and resources. For more information, visit emblemhealth.com.

Contact: 
EmblemHealth Public Relations Office| Email: press@emblemhealth.com


Alex Gomez
EmblemHealth
agomez@emblemhealth.com

More News

View More
Amazon Earnings: 3 Catalysts That Could Drive Shares to $300
October 31, 2025
Via MarketBeat
Tickers AMZN GOOG GOOGL
Why Chipotle Stock May Bounce After a Brutal Sell-Off
October 31, 2025
Via MarketBeat
Tickers CMG
Why VGT May Be a Smarter Bet Than Chasing Individual Tech Stocks
October 31, 2025
Via MarketBeat
Tickers AAPL AVGO MSFT NVDA VGT
Equinix Stock Rises Despite Lower Revenue Guidance
October 31, 2025
Via MarketBeat
Tickers EQIX META MSFT
MongoDB: It’s No Trick, This AI Play Is a Treat
October 31, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers MDB

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.22
+21.36 (9.58%)
AAPL  270.37
-1.03 (-0.38%)
AMD  256.12
+1.28 (0.50%)
BAC  53.45
+0.42 (0.79%)
GOOG  281.82
-0.08 (-0.03%)
META  648.35
-18.12 (-2.72%)
MSFT  517.81
-7.95 (-1.51%)
NVDA  202.49
-0.40 (-0.20%)
ORCL  262.61
+5.72 (2.23%)
TSLA  456.56
+16.46 (3.74%)
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap